Cognitive Rehabilitation in Sickle Cell Disease
|ClinicalTrials.gov Identifier: NCT01793740|
Recruitment Status : Completed
First Posted : February 18, 2013
Last Update Posted : August 20, 2014
|Condition or disease||Intervention/treatment||Phase|
|Sickle Cell Disease Cognitive Impairment||Behavioral: Cogmed||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||18 participants|
|Intervention Model:||Crossover Assignment|
|Masking:||None (Open Label)|
|Official Title:||Cognitive Rehabilitation of Children With Sickle Cell Disease: A Pilot Study|
|Study Start Date :||October 2012|
|Actual Primary Completion Date :||July 2014|
|Actual Study Completion Date :||July 2014|
These children are enrolled in the Cogmed intervention.
Computer based program that aims to improve children's memory, attention, and processing speed.
Other Name: Cogmed computerized cognitive training
No Intervention: Waitlist
These children are enrolled in a waitlist condition, after which they will be offered the opportunity to complete the intervention.
- Feasibility [ Time Frame: Post-study - Baseline to Post-Intervention, approximately 5 to 8-weeks after baseline assessment ]Feasibility is defined as 75% of subjects completing 80% of the training program.
- Efficacy [ Time Frame: Baseline to Post-Intervention, approximately 5 to 8-weeks after baseline assessment ]Efficacy will be defined by participant performance on cognitive outcome measures including executive functioning outcomes from the Cogstate.
- Acceptance [ Time Frame: After the recruitment period has been completed (approximately 2-years) ]Acceptance is defined by 50% of those approached are able to participate/consent to the study.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01793740
|United States, North Carolina|
|Duke Child and Family Study Center|
|Durham, North Carolina, United States, 27705|
|Principal Investigator:||Melanie J Bonner, PhD||Duke University|